Source author record

Yaman Aksu

Yaman Aksu appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
3topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2014arXiv

Fast SVM-based Feature Elimination Utilizing Data Radius, Hard-Margin, Soft-Margin

Margin maximization in the hard-margin sense, proposed as feature elimination criterion by the MFE-LO method, is combined here with data radius utilization to further aim to lower generalization error, as several published bounds and bound-related formulations pertaining to lowering misclassification risk (or error) pertain to radius e.g. product of squared radius and weight vector squared norm. Additionally, we propose additional novel feature elimination criteria that, while instead being in the soft-margin sense, too can utilize data radius, utilizing previously published bound-related formulations for approaching radius for the soft-margin sense, whereby e.g. a focus was on the principle stated therein as "finding a bound whose minima are in a region with small leave-one-out values may be more important than its tightness". These additional criteria we propose combine radius utilization with a novel and computationally low-cost soft-margin light classifier retraining approach we devise named QP1; QP1 is the soft-margin alternative to the hard-margin LO. We correct an error in the MFE-LO description, find MFE-LO achieves the highest generalization accuracy among the previously published margin-based feature elimination (MFE) methods, discuss some limitations of MFE-LO, and find our novel methods herein outperform MFE-LO, attain lower test set classification error rate. On several datasets that each both have a large number of features and fall into the `large features few samples' dataset category, and on datasets with lower (low-to-intermediate) number of features, our novel methods give promising results. Especially, among our methods the tunable ones, that do not employ (the non-tunable) LO approach, can be tuned more aggressively in the future than herein, to aim to demonstrate for them even higher performance than herein.

preprint2011arXiv

An MRI-Derived Definition of MCI-to-AD Conversion for Long-Term, Automati c Prognosis of MCI Patients

Alzheimer's disease (AD) and mild cognitive impairment (MCI), continue to be widely studied. While there is no consensus on whether MCIs actually "convert" to AD, the more important question is not whether MCIs convert, but what is the best such definition. We focus on automatic prognostication, nominally using only a baseline image brain scan, of whether an MCI individual will convert to AD within a multi-year period following the initial clinical visit. This is in fact not a traditional supervised learning problem since, in ADNI, there are no definitive labeled examples of MCI conversion. Prior works have defined MCI subclasses based on whether or not clinical/cognitive scores such as CDR significantly change from baseline. There are concerns with these definitions, however, since e.g. most MCIs (and ADs) do not change from a baseline CDR=0.5, even while physiological changes may be occurring. These works ignore rich phenotypical information in an MCI patient's brain scan and labeled AD and Control examples, in defining conversion. We propose an innovative conversion definition, wherein an MCI patient is declared to be a converter if any of the patient's brain scans (at follow-up visits) are classified "AD" by an (accurately-designed) Control-AD classifier. This novel definition bootstraps the design of a second classifier, specifically trained to predict whether or not MCIs will convert. This second classifier thus predicts whether an AD-Control classifier will predict that a patient has AD. Our results demonstrate this new definition leads not only to much higher prognostic accuracy than by-CDR conversion, but also to subpopulations much more consistent with known AD brain region biomarkers. We also identify key prognostic region biomarkers, essential for accurately discriminating the converter and nonconverter groups.